Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph1b/2 Study to Evaluate Oleclumab (MEDI9447) with or without Durvalumab w Chemo in Pancreatic Ca

Protocol: OSU-18158

Full Title

A Phase 1b/2 Study to Evaluate the Safety,Pharmacokinetics, and Clinical Activity of Oleclumab (MEDI9447) with or without Durvalumab in Combination with Chemotherapy in Subjects with Metastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Cancer